ym888
Senior Member
- Joined
- Mar 11, 2021
- Messages
- 1,937
- Likes
- 1,207
Break the monopoly! China has realized the full domestic supply of carbon-14
At 13:48 on April 20, the carbon-14 target was successfully extracted from the Qinshan Nuclear Power heavy water reactor unit owned by China Nuclear Power Investment Co., LTD., which is the first time that China has used a nuclear power commercial reactor to mass produce carbon-14 isotope.
It is understood that carbon-14 isotope is widely used in agriculture, chemistry, medicine, biology and other fields, with high medical and scientific value, the main applications include Helicobacter pylori detection, pharmacokinetic research, beta ray environmental monitoring system and so on.
After the completion of the carbon-14 target reactor, it will be supplied to the market by the end of 2024 after back-end processing, and the output can fully meet the domestic demand, which will strongly promote the development of China's isotope application industry chain, and further establish and improve the research and development system of industrial, academic and research cooperation in commercial reactor irradiation production of isotopes. Boost and pull the research and development of high-tech nuclear drugs and nuclear medical industry of downstream medical enterprises, and provide strong support for the development of domestic isotope application industry.
In addition, during this period of carbon-14 targets out of the reactor, Qinshan Nuclear Power Plant also carried out the installation and commissioning of the reactor roof irradiation production device. After the plant is put into use, it will be able to produce lutetium-177, yttrium-90 and other isotopes by irradiation on a large scale.
At 13:48 on April 20, the carbon-14 target was successfully extracted from the Qinshan Nuclear Power heavy water reactor unit owned by China Nuclear Power Investment Co., LTD., which is the first time that China has used a nuclear power commercial reactor to mass produce carbon-14 isotope.
It is understood that carbon-14 isotope is widely used in agriculture, chemistry, medicine, biology and other fields, with high medical and scientific value, the main applications include Helicobacter pylori detection, pharmacokinetic research, beta ray environmental monitoring system and so on.
After the completion of the carbon-14 target reactor, it will be supplied to the market by the end of 2024 after back-end processing, and the output can fully meet the domestic demand, which will strongly promote the development of China's isotope application industry chain, and further establish and improve the research and development system of industrial, academic and research cooperation in commercial reactor irradiation production of isotopes. Boost and pull the research and development of high-tech nuclear drugs and nuclear medical industry of downstream medical enterprises, and provide strong support for the development of domestic isotope application industry.
In addition, during this period of carbon-14 targets out of the reactor, Qinshan Nuclear Power Plant also carried out the installation and commissioning of the reactor roof irradiation production device. After the plant is put into use, it will be able to produce lutetium-177, yttrium-90 and other isotopes by irradiation on a large scale.